IP Library Granted Patent US 9,089,408
Granted Patent B2
US 9,089,408 · App. 13/764,816 · Granted Jul 28, 2015

Biodegradable metallic medical implants, method for preparing and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,408
App. No.
13/764,816
Granted
Jul 28, 2015
Kind
B2
Abstract

A medical implant includes a metal composite that contains a cellular nanomatrix having a metallic nanomatrix material and a metal matrix disposed in the cellular nanomatrix, the medical implant being configured to disintegrate in response to contact with a fluid. A method for repairing tissue includes disposing an implant in a patient, the implant including a metal composite which contains: a cellular nanomatrix having a metallic nanomatrix material; and a metal matrix disposed in the cellular nanomatrix; contacting tissue of the patient with the implant, the tissue being in need of repair; and non-operatively removing the implant to repair the tissue.

Claims (23)

1. A method for repairing tissue, the method comprising:

disposing an implant in a patient, the implant comprising a metal composite which comprises:

a cellular nanomatrix comprising a metallic nanomatrix material; and

a metal matrix disposed in the cellular nanomatrix;

contacting tissue of the patient with the implant, the tissue being in need of repair; and

allowing the implant to disintegrate as the tissue repairs;

wherein the metal matrix comprises a particle core material that is discontinuously and discretely distributed as particles within the metal composite.

2. The method of claim 1 , wherein allowing the implant to disintegrate comprises disintegrating the implant by contacting the implant with a fluid comprising blood, a blood substitute, saline, a salt, an organic acid, a buffer, an alkaline compound, a protein, an amino acid, a nucleic acid, an enzyme, a carbohydrate, a gas, bone marrow, a tissue, serum, plasma, urine, semen, a lacrimal secretion, saliva, cerebrospinal fluid, sweat, synovial fluid, a mucous secretion, lymph, or a combination thereof.

3. The method of claim 2 , wherein the disposing step comprises disposing an implant that has an in vitro lifetime effective for the implant to stabilize the tissue during repair and to disintegrate at a rate such that an amount of gas production and blood alkalization from a product of disintegrating the implant is biologically tolerable and non-toxic to the patient.

4. The method of claim 1 , further comprising bending, drilling, twisting, compressing, stretching the implant, or a combination thereof, prior to disposing the implant in the patient.

5. The method of claim 1 , further comprising growing additional tissue on the implant.

6. The method of claim 1 , wherein the disposing step comprises disposing an implant that has a nanoscale thickness between adjacent particles of the metal matrix.

7. The method of claim 1 , wherein the disposing step comprises disposing an implant that has the metal matrix comprising magnesium; and the metallic nanomatrix material comprising aluminum, calcium, cobalt, copper, iron, molybdenum, nickel, silicon, zinc, an intermetallic compound thereof, or a combination thereof.

8. The method of claim 7 , wherein the disposing step comprises disposing an implant that has the metal matrix further comprising aluminum, calcium, copper, iron, manganese, zinc, or a combination thereof.

9. The method of claim 7 , wherein the disposing step comprises disposing an implant that has the metal matrix in the form of an alloy.

10. The method of claim 1 , wherein the disposing step comprises disposing an implant that has the metal matrix comprising magnesium and the metallic nanomatrix material comprising aluminum oxide.

11. The method of claim 1 , wherein the disposing step comprises disposing an implant that has the metal composite further comprising a disintegrating agent comprising cobalt, copper, iron, nickel, or a combination comprising at least one of the foregoing.

12. The method of claim 1 , wherein the disposing step comprises disposing an implant that has a disintegration rate from 0.1 mg/cm 2 /hr to 100 mg/cm 2 /hr.

13. The method of claim 1 , wherein the disposing step comprises disposing an implant that has a percent elongation from 0.1% to 25% and a compressive strength of about 30 ksi to about 80 ksi.

14. The method of claim 1 , wherein the disposing step comprises disposing an implant comprising a plurality of components, each component comprising the metal composite and having a same or different disintegration rate.

15. The method of claim 14 , wherein the disposing step comprises disposing an implant wherein the plurality of components comprises:

a first component; and

a second component attached to or interworking with the first component.

Assignments (3)
CHANGE OF NAME Recorded Apr 6, 2022
From: BAKER HUGHES, A GE COMPANY, LLC
To: BAKER HUGHES HOLDINGS LLC
Reel/Frame 059620/0651 →
CHANGE OF NAME Recorded Mar 24, 2022
From: BAKER HUGHES INCORPORATED
To: BAKER HUGHES, A GE COMPANY, LLC
Reel/Frame 059497/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2013
From: XU, ZHIYUE
To: BAKER HUGHES INCORPORATED
Reel/Frame 030084/0896 →